R. Kiplin Guy, St. Jude Children's Research Hospital (IMAGE)

St. Jude Children's Research Hospital

R. Kiplin Guy, St. Jude Children's Research Hospital

Caption

An international research collaborative led by St. Jude Children's Research Hospital reports that the rapid action of (+)-SJ733 will likely slow malaria drug resistance. Human safety trials of the compound are planned.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.